Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France
Bernard Castan, David Boutoille(Inserm), A. Berthelot(MSD (France)), Lucie Mathis(MSD (France)), Carole Mackosso(MSD (France)), Jean‐François Timsit(Université Claude Bernard Lyon 1), Brune Akrich(MSD (France)), L. Lévy-Bachelot, Fabrice Ruiz(Monal Group (France)), Raymond Ruimy(Hôpital l'Archet), Joy Mootien(Centre Hospitalier de Mulhouse), Anna Amode
Cited by 8
Related Papers
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
|Intensive Care Medicine|2012|449
Determinants of Procedural Pain Intensity in the Intensive Care Unit. The Europain® Study
|American Journal of Respiratory and Critical Care Medicine|2013|369